Proliferation in African breast cancer: biology and prognostication in nigerian breast cancer material.

Department of Pathology, University of Calabar Teaching Hospital, Nigeria.
Modern Pathology (Impact Factor: 6.36). 08/2002; 15(8):783-9. DOI: 10.1097/01.MP.0000021764.03552.BD
Source: PubMed

ABSTRACT Three hundred cases of invasive breast carcinoma from the University of Calabar Teaching Hospital, Nigeria were subjected to evaluation of proliferative activity by mitotic counts. The prognostic significance and association with other prognostic factors were evaluated. The mitotic activity was expressed as mitotic activity index (MAI), and standardized mitotic index (SMI). Pearson's correlation and univariate and multivariate Cox's regression were used. The mean follow-up time was 25.9 months. The mean values of SMI and MAI were 42.6 mitotic figures per square millimeter and 30.5 mitotic figures per 10 high-power fields, respectively, and these were much higher than values reported for Europe or other Western countries. The SMI had a positive correlation with tumor size (r = 0.31, P <.0001), histologic grade (r = 0.68, P <.0001), nuclear area (r = 0.45, P <.0001), and negative correlation with fraction of fields with tubular differentiation (FTD; r = -0.56, P = <0.0001). There was no statistically significant difference in the mitotic activity between the postmenopausal and the premenopausal patients. Also, lymph node-positive patients had higher counts than did lymph node-negative patients. Earlier determined grading associated decision thresholds divided the patients into groups of favorable and unfavorable prognosis. However, the statistically optimal thresholds for Nigerian material were different (32 and 92 mitotic figures per square millimeter for SMI). Tumor size of 5 cm, SMI, and MAI were independent prognostic factors. Nigerian breast cancers are high-grade, high-stage, and high-proliferating cancers occurring in a younger population than those of the Western countries. Proliferation is also more active. Evaluation of SMI or MAI can improve the distinction between aggressive and less aggressive variants of breast cancer.

1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The objective of this study was to evaluate the overall five year survival rate, pattern of disease presentation, and to determine some factors that are predictive of five years survival among patients diagnosed and managed for breast cancer between 2005 and 2011 . Background information and histological type were obtained from the patients records. Clinical, Radiological, Staging (Manchester) and site of metastasis information were obtained during pre-treatment examination and follow-up periods. At presentation, stage III was (45.6%) followed by stage IV (35%) stage I, 2.4% and II with 16.6%. The overall five year survival in the population studied was 25.6% (45/176). Five year survival rates for patients with stages II, III and IV diseases at diagnosis were 45%, 15% and 5% respectively. Five year survival rate for early stages (I and II) was 45% while advanced stages (III&IV) was 16%. The median survival time for the patients studied was 30 (28.5-31.5 95%CI) months. Hazard ratio (HR) of 1.28(0.96-1.72) was obtained for disease stages above stage 1 at presentation relative to stage 1 disease. A greater percentage of our patient presented at young peak age of incidence in advanced stages of the disease and with aggressive tumour which may have resulted in poor survival outcome. These factors should be considered when planning health programmes to improve survival in this group of patients. Further study and researches are required to determine the characteristics of each tumour for effective treatment and better outcome.
  • [Show abstract] [Hide abstract]
    ABSTRACT: African American women have a lower lifetime incidence of breast cancer than white/Caucasian Americans yet have a higher risk of breast cancer mortality. African American women are also more likely to be diagnosed with breast cancer at young ages, and they have higher risk for the biologically more aggressive triple-negative breast cancers. These features are also more common among women from western, sub-Saharan Africa who share ancestry with African Americans, and this prompts questions regarding an association between African ancestry and inherited susceptibility for certain patterns of mammary carcinogenesis.
    Surgical Oncology Clinics of North America 07/2014; 23(3):579-592. DOI:10.1016/j.soc.2014.03.014 · 1.67 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Breast cancer is the commonest cause of cancer-related deaths in the world. There is paucity of data on breast cancer incidence, epidemiological features, treatment and survival in our environment and, thus, the aim of this study is to document our findings on the clinical characteristics and survival outcome of patients seen in one of the teaching hospitals in Nigeria. Materials and methods This is a prospective non-selective cohort study of 139 consecutive cases of breast cancer seen in Olabisi Onabanjo University Teaching Hospital in Sagamu, Ogun State, Nigeria, from 1st January 2004 to 31st December 2008. Appropriate treatment was given after histological confirmation. Follow up was for a minimum of 36 months. Patients were classified into various groups based on age, menstrual status, parity, body mass index (BMI), histological stage and lump size. Results were analyzed using SPSS, and were expressed in percentages and frequency tables. Kaplan-Meier survival curves were constructed for each group and test of equality of survival for each group, Mantel-Cox, was done. A p value of Results All 139 patients were female. The mean age was 48.1, and commonest symptom was lumps in 100 (72%) cases and mean duration of symptoms was 10.1 months. The mean lump size was 8.2 cm. Five patients had Manchester stage 1 while 39 patients (28%) had stage 4. The mean duration of survival was 29.8 months. Sixty-three (45.2%) patients survived for 36 months and more. There was no significant difference in survival in patients who were below 40 years and those above 40 years. Survival was better in patients with lumps less than 5 cm than those with lumps bigger than 5 cm (p p = 0.015) stage and at stages 1 and 2 than stages 3 and 4 (p Conclusion Breast cancer presentation and survival in our study is characterized by late presentation, affecting predominantly premenopausal women and with poor overall survival. There is a need to increase awareness and set up screening programmes to promote early detection and treatment.
    Journal africain du cancer / African Journal of Cancer 05/2014; 6(2):79-84. DOI:10.1007/s12558-014-0311-8

Full-text (2 Sources)

Available from
May 31, 2014